Ho­mol­o­gy shut­ters de­vel­op­ment as ge­net­ic med­i­cines biotech flash­es ‘for sale’ sign, lays off 80 em­ploy­ees

Gene edit­ing and gene ther­a­py mak­er Ho­mol­o­gy Med­i­cines is let­ting go near­ly all of its staff, end­ing clin­i­cal de­vel­op­ment and search­ing for a buy­er or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER